RNAC Cash & Short-Term Investments

Cartesian Therapeutics Inc · Cash & Short-Term Investments

RNAC logo

RNAC Cash & Short-Term Investments

Latest reported$125.14M
RNAC FY Cash & Short-Term Investments ($16.59M → $125.14M)
High-resolution chart · PNG

RNAC cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
125,139,000
212,610,000
76,911,000
134,602,000
128,055,000
138,685,000
90,172,000
37,403,000
96,638,000
84,141,000
36,462,000
16,592,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.